{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:57:28Z","timestamp":1791176248310,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.vaccine.2011.05.098","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T05:29:43Z","timestamp":1308893383000},"page":"5758-5764","source":"Crossref","is-referenced-by-count":42,"title":["A new oral vaccine candidate based on the microencapsulation by spray-drying of inactivated Vibrio cholerae"],"prefix":"10.1016","volume":"29","author":[{"given":"Gemma","family":"A\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaia","family":"Esquisabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Talavera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara","family":"Cedr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonsire","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Sifontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisabel","family":"Aranguren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Falero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Lydia","family":"Sol\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Pedraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.05.098_bib0005","unstructured":"WHO. Oral cholera vaccine use in complex emergencies: What next? World Health Organization, 2005. [cited 2010 December 22]. Available from http:\/\/www.who.int\/cholera\/publications\/cholera_vaccines_emergencies_2005.pdf."},{"issue":"8","key":"10.1016\/j.vaccine.2011.05.098_bib0010","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1473-3099(07)70138-X","article-title":"The true burden and risk of cholera: implications for prevention and control","volume":"7","author":"Zuckerman","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2011.05.098_bib0015","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3855\/jidc.410","article-title":"Is cholera disease associated with poverty?","volume":"3","author":"Talavera","year":"2009","journal-title":"J Infect Dev Ctries"},{"issue":"8","key":"10.1016\/j.vaccine.2011.05.098_bib0020","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMoa043323","article-title":"Effectiveness of mass oral cholera vaccination in Beira, Mozambique","volume":"352","author":"Lucas","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.05.098_bib0025","series-title":"Development of vaccines and drugs against diarrhea","first-page":"33","article-title":"Oral combined B subunit-whole cell cholera vaccine 1986","author":"Svennerholm","year":"1986"},{"issue":"3","key":"10.1016\/j.vaccine.2011.05.098_bib0030","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1473-3099(07)70032-4","article-title":"Cholera vaccines","volume":"7","author":"Kabir","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"16","key":"10.1016\/j.vaccine.2011.05.098_bib0035","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1016\/j.vaccine.2005.12.064","article-title":"Formulation in tablets of a cholera whole cells inactivated vaccine candidate","volume":"24","author":"Talavera","year":"2006","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2011.05.098_bib0040","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1473-3099(06)70494-7","article-title":"Oral cholera vaccines: use in clinical practice","volume":"6","author":"Hill","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"20","key":"10.1016\/j.vaccine.2011.05.098_bib0045","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1016\/j.vaccine.2006.03.008","article-title":"Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam","volume":"24","author":"Thiem","year":"2006","journal-title":"Vaccine"},{"issue":"9047","key":"10.1016\/j.vaccine.2011.05.098_bib0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(96)06107-7","article-title":"Field trial of a locally produced, killed, oral cholera vaccine in Vietnam","volume":"349","author":"Trach","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.05.098_bib0055","doi-asserted-by":"crossref","unstructured":"Kabir S. Questionable merits of the field trial of an oral killed whole cell cholera vaccine in Vietnam during 1998\u20132003. Vaccine; 25(8):1353\u20134.","DOI":"10.1016\/j.vaccine.2006.09.057"},{"issue":"6","key":"10.1016\/j.vaccine.2011.05.098_bib0060","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1517\/17425247.3.6.747","article-title":"Delivery systems and adjuvants for oral vaccines","volume":"3","author":"Lavelle","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"10.1016\/j.vaccine.2011.05.098_bib0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/02652040310001619794","article-title":"Inactive Vibrio cholerae whole-cell vaccine-loaded biodegradable microparticles: in vitro release and oral vaccination","volume":"21","author":"Yeh","year":"2004","journal-title":"J Microencapsul"},{"issue":"1","key":"10.1016\/j.vaccine.2011.05.098_bib0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1292\/jvms.65.69","article-title":"Protective effects of oral microencapsulated Mycoplasma hyopneumoniae vaccine prepared by co-spray drying method","volume":"65","author":"Lin","year":"2003","journal-title":"J Vet Med Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2011.05.098_bib0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1081\/PDT-100100541","article-title":"Production of Eudragit microparticles by spray-drying technique: influence of experimental parameters on morphological and dimensional characteristics","volume":"5","author":"Esposito","year":"2000","journal-title":"Pharm Dev Technol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2011.05.098_bib0080","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0378-5173(02)00176-X","article-title":"Spray dried Eudragit microparticles as encapsulation devices for vitamin C","volume":"242","author":"Esposito","year":"2002","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.vaccine.2011.05.098_bib0085","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.1208\/pt070112","article-title":"Spray-dried mucoadhesive microspheres: preparation and transport through nasal cell monolayer","volume":"7","author":"Harikarnpakdee","year":"2006","journal-title":"AAPS Pharm Sci Technol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.05.098_bib0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.powtec.2006.09.007","article-title":"Spray drying conditions and encapsulating composition effects on formation and properties of sodium diclofenac microparticles","volume":"171","author":"Ribeiro Rattes","year":"2007","journal-title":"Powder Technol"},{"key":"10.1016\/j.vaccine.2011.05.098_bib0095","unstructured":"Evonik R\u00f6hm GmbH. Guidelines for Formulation Development and Process Technology for Enteric Coatings, 2009. [cited 2010 December 22]. Available from http:\/\/eudragit.evonik.com\/sites\/dc\/Downloadcenter\/Evonik\/Product\/EUDRAGIT\/Guidelines%20for%20Formulation%20Development%20and%20Process%20Technology%20for%20Enteric%20Coatings.pdf."},{"issue":"4","key":"10.1016\/j.vaccine.2011.05.098_bib0100","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1128\/IAI.70.4.2022-2028.2002","article-title":"Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.05.098_bib0105","first-page":"9","article-title":"Antigenicidad e inmunogenicidad de una cepa de Vibrio cholerae inactivada","volume":"20","author":"A\u00f1o","year":"2003","journal-title":"Biotecnolog\u00eda Aplicada"},{"issue":"12","key":"10.1016\/j.vaccine.2011.05.098_bib0110","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1348-0421.2006.tb03866.x","article-title":"The ABCs (antibody, B cells, and carbohydrate epitopes) of cholera immunity: considerations for an improved vaccine","volume":"50","author":"Provenzano","year":"2006","journal-title":"Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.05.098_bib0115","first-page":"156","article-title":"Estandarizaci\u00f3n y evaluaci\u00f3n del ensayo vibriocida modificado","volume":"51","author":"Cedr\u00e9","year":"1999","journal-title":"Rev Cubana Med Trop"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2011.05.098_bib0120","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1016\/S0264-410X(03)00388-8","article-title":"Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits","volume":"21","author":"Eko","year":"2003","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2011.05.098_bib0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/02652040802190937","article-title":"Retained integrity of protein encapsulated in spray-dried chitosan microparticles","volume":"26","author":"Kusonwiriyawong","year":"2009","journal-title":"J Microencapsul"},{"issue":"6","key":"10.1016\/j.vaccine.2011.05.098_bib0130","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/02652040701452917","article-title":"Production of BSA-loaded alginate microcapsules: influence of spray dryer parameters on the microcapsule characteristics and BSA release","volume":"24","author":"Benchabane","year":"2007","journal-title":"J Microencapsul"},{"issue":"1","key":"10.1016\/j.vaccine.2011.05.098_bib0135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijpharm.2006.06.045","article-title":"Sodium pantoprazole-loaded enteric microparticles prepared by spray drying: effect of the scale of production and process validation","volume":"324","author":"Raffin","year":"2006","journal-title":"Int J Pharm"},{"issue":"7","key":"10.1016\/j.vaccine.2011.05.098_bib0140","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/10611860903067301","article-title":"Oral delivery of gastro-resistant microencapsulated typhoid vaccine","volume":"17","author":"Uddin","year":"2009","journal-title":"J Drug Target"},{"issue":"1","key":"10.1016\/j.vaccine.2011.05.098_bib0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/10010065","article-title":"Polymeric particulates to improve oral bioavailability of peptide drugs","volume":"10","author":"Delie","year":"2005","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.vaccine.2011.05.098_bib0150","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addr.2006.01.002","article-title":"Mucosal delivery of vaccine antigens and its advantages in pediatrics","volume":"58","author":"De Magistris","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2011.05.098_bib0155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1461-5347(98)00024-8","article-title":"Microparticulate delivery systems: potential drug\/vaccine carriers via mucosal routes","volume":"1","author":"Hillery","year":"1998","journal-title":"Pharm Sci Technol Today"},{"issue":"9","key":"10.1016\/j.vaccine.2011.05.098_bib0160","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.addr.2005.01.014","article-title":"Microencapsulated subunit vaccine approach to enterotoxigenic Escherichia coli and other mucosal pathogens","volume":"57","author":"Byrd","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2011.05.098_bib0165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0168-3659(02)00140-2","article-title":"Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles","volume":"82","author":"Yeh","year":"2002","journal-title":"J Control Release"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2011.05.098_bib0170","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0264-410X(00)00083-9","article-title":"Passive protection of serum from volunteers inoculated with attenuated strain 638 of Vibrio cholerae O1 in animal models","volume":"19","author":"Perez","year":"2000","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2011.05.098_bib0175","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1023\/A:1015867915809","article-title":"Tablet formulation study of spray-dried sodium diclofenac enteric-coated microcapsules","volume":"8","author":"Lin","year":"1991","journal-title":"Pharm Res"},{"issue":"12","key":"10.1016\/j.vaccine.2011.05.098_bib0180","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1086\/421275","article-title":"Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh","volume":"189","author":"Saha","year":"2004","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2011.05.098_bib0185","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/IAI.67.2.539-545.1999","article-title":"Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin\/protease-defective El Tor strain as a cholera vaccine candidate","volume":"67","author":"Benitez","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.05.098_bib0190","unstructured":"M. Corbel, D. Garcia, E. Griffiths. Guidelines for the production and control of inactivated oral cholera vaccines. 2004. WHO Technical Series Report No. 924."},{"issue":"5","key":"10.1016\/j.vaccine.2011.05.098_bib0195","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/IAI.01900-06","article-title":"Broad up-regulation of innate defense factors during acute cholera","volume":"75","author":"Flach","year":"2007","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2011.05.098_bib0200","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1128\/IAI.73.5.3018-3024.2005","article-title":"The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers","volume":"73","author":"Garcia","year":"2005","journal-title":"Infect Immun"},{"issue":"18","key":"10.1016\/j.vaccine.2011.05.098_bib0205","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1016\/j.vaccine.2005.07.015","article-title":"Process development for a Cuban cholera vaccine based on the attenuated strain Vibrio cholerae 638","volume":"24","author":"Talavera","year":"2006","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11008644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11008644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T12:18:01Z","timestamp":1592655481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11008644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":41,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0264410X11008644"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.05.098","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}